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NC-ND license (http://creativecommoSummary Background/Objective: Pilonidal sinus treatment includes various surgical and
minimally invasive procedures, but there is still no standard treatment. Flap reconstructions
and minimally invasive treatment options such as crystallized phenol application have recently
been in the center of interest. The aim of this study is to compare crystallized phenol appli-
cation as a minimally invasive treatment with modified Limberg flap reconstruction from many
aspects.
Methods: Thirty-seven patients diagnosed with pilonidal sinus and treated with modified Lim-
berg flap reconstruction, and 44 patients treated with crystallized phenol application were
evaluated retrospectively in terms of age, sex, length of stay in hospital postoperatively,
wound complications, and the cause and rate of recurrence.
Results: Length of hospital stay was decreased and no postoperative incision problems were
found in the group treated with crystallized phenol application (p < 0.001 and p Z 0.011,
respectively). The difference between the groups in terms of recurrence rate was not statis-
tically significant (pZ 0.173). Although the recurrence rate was found to be higher in the pa-
tient group treated once with crystallized phenol application, the success rate following
multiple applications of crystallized phenol was found to be 94.5%. Higher body mass index
(> 24.9 kg/m2) and surgical site infection were strongly correlated with recurrence rate
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Crystallized phenol treatment 173Discussion: Crystallized phenol application is a good alternative to the modified Limberg flap
procedure and other surgical procedures, because it has several advantages such as being a
minimally invasive procedure performed under local anesthesia with higher success rate after
multiple applications, decreased length of stay in hospital, and minimal scar tissue formation.
Copyright ª 2016, Asian Surgical Association. Published by Elsevier Taiwan LLC. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Pilonidal sinus is a common disease of the sacrococcygeal
region that is usually seen among young men. Numerous
theories have been presented to explain its etiology, but
the widely accepted view is that the disease is acquired.1
Although some of the patients experience severe acute
pain, the disease manifests itself with chronic-continuous
discharge. Because there is no standard treatment, and it
has a high recurrence rate, studies on pilonidal sinus have a
potential value.2 Treatment options of pilonidal sinus vary
from minimally invasive surgical interventions to compli-
cated flap techniques; yet none of them were suggested as
the most effective procedure so far.3 Although some studies
report that flap techniques are associated with lower
recurrence rates and higher patient satisfaction in com-
parison with other surgical procedures, there are several
studies suggesting that flap techniques are extreme surgical
procedures.4e6 Modified Limberg flap reconstruction was
first described by Mentes et al7 in 2004. In this technique,
the lower edge of the incision is shifted laterally from the
midline to prevent the inferomedial recurrence seen in
classical Limberg flap reconstruction. The lower recurrence
and complication rates in modified Limberg flap recon-
struction in comparison with classical Limberg flap recon-
struction8,9 and other conversional flap reconstruction
techniques10,11 were reported in several studies.
The ideal treatment of pilonidal sinus disease should
include minimum tissue excision with a lower recurrence
rate. Additionally, the postoperative period should include
short length of stay in the hospital, fast recovery back to
normal life, minimum workforce loss, and minimal scar
tissue formation. Thus, easily performed treatments such
as pit excision, mechanical clearance of the sinus tract, and
chemical therapies became popular.12
Phenol, also known as carbolic acid, has antiseptic, anes-
thetic, and strong sclerotic features. Phenol treatment is one
of the current popular conservative options to treat pilonidal
sinus. It can be used both in liquid or crystallized form.13
In the present study, crystallized phenol application as a
minimally invasive treatment was compared with modified
Limberg flap reconstruction as a current surgical treatment
of pilonidal sinus from many aspects.2. Methods
Between December 2013 and July 2015, a total of 94
patients were diagnosed with pilonidal sinus and treated at
Dumlupınar University Evliya C¸elebi Research andEducation Hospital in Kutahya, Turkey. Their details were
examined retrospectively in terms of age, sex, length of
stay in hospital postoperatively, wound complications,
recurrence rate, and recurrence causes.
Patients aged between 18 years and 65 years with pilo-
nidal sinus disease who have not undergone any prior
treatment were included in the study. The exclusion
criteria include being under treatment for steroids, appli-
cation to the clinic with a recurrence disease, being diag-
nosed with diabetes mellitus, being diagnosed with abscess
formation following pilonidal disease, and concomitant
pilonidal disease with malignant conditions.
Deep sinuses are not accepted as a contraindication for
phenol treatment and can be managed as easily as super-
ficial ones. Because phenol contact with cavity wall is
enough to induce this effect, even a small amount of
crystals can easily fill almost every cavity of pilonidal
sinuses by melting at body temperature. Thus, patients
with deep sinuses were not excluded from the study.
Forty-four of the patients were treated with modified
Limberg flap reconstruction, whereas 37 patients were
treated with crystallized phenol application. The patients
with a higher body mass index (BMI; > 24.9 kg/m2) were
grouped as overweight according to the National Heart,
Lung, and Blood Institute guidelines.14
A written consent was obtained from all participants. No
patient identity information was disclosed, and there was
no need for ethical approval as this is a retrospective study.
2.1. Surgical procedures
2.1.1. Crystallized phenol application
Crystallized phenol application was performed in 37 of the
patients as described by Akan et al.13 After the application
of local anesthetic, a millimetric circumferential incision
was made to excise the pits with a fine blade. With the help
of a curved clamp hair, debris and granulation tissue were
removed from the sinus tract and the tract is curetted.
Prior to crystallized phenol application, a pomade
containing nitrofurantoin was applied in order to protect
the surrounding tissue, and after that crystallized phenol
particles were inserted to the tract with the help of a clamp
(Figure 1). After dressing, the procedure was terminated
and the patient was discharged immediately. The applica-
tion was performed by an experienced surgical team.
2.1.2. Modified Limberg flap reconstruction group
The operation was performed as described by Mentes et al.7
The skin incision was first marked out with a sterile pen and
ruler, then a rhomboid excision including postsacral fascia
Figure 1 After the pit excision and curettage of the sinus.
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end of the excision was extended 2 cm laterally from the
midline to the opposite side of the donor area of the flap. A
fasciocutaneous flap was prepared from the right or the left
side of the gluteal region including gluteal fascia, then the
flap was placed over a hemovac drain and sutured to the
presacral fascia (Figures 2A and 2B). The operations were
performed by the same surgical team.Figure 2 After modified Lim2.2. Statistical analysis
Normality of the distribution of variables was determined
using KolmogoroveSmirnov test. Data were expressed as
numbers and percentages for categorical variables and
mean  standard deviation for continuous variables. Nor-
mally distributed data were compared using Student t test,
whereas data with skewed distribution were compared with
KruskaleWallis test. Statistical differences were considered
significant when p was < 0.05. Statistical analyses were
performed with SPSS 18 for Windows (SPSS Inc., Chicago, IL,
USA).3. Results
Forty-four of the patients were treated with modified
Limberg flap reconstruction, whereas 37 patients were
treated with crystallized phenol application. Female pa-
tients in the group treated with modified Limberg flap
reconstruction represented 13.6% (n Z 6) of the total,
whereas in the group treated with crystallized phenol
application women accounted for 21.6% (n Z 8); the me-
dian ages of patients in the Flap group and the Phenol group
were 25.4  5.9 years and 26  6.6 years, respectively.
There were no significant differences in age, sex, infection,
and presence of hematoma between the two groups.
Length of hospital stay in the group treated with modified
Limberg flap reconstruction was calculated as
1.25  0.4 days, whereas patients in the group treated with
crystallized phenol application were discharged immedi-
ately after the procedure. Thus, shorter length of hospital
stay and no postoperative incision problems were noted in
the group treated with crystallized phenol application
(p < 0.001). Wound dehiscence was noted in seven patients
(15.9%) in the group treated with modified Limberg flap
reconstruction. Follow-up periods of patients in the Flap
group and Phenol group were 17.9  2.6 months and
16.5  4.4 months, respectively, and no significant differ-
ence between the two groups was found in terms of body
mass (24.2  2.6 and 24.5  2.7, respectively; Table 1).
Recurrence was noted in three patients (6.8%) in the
group treated with modified Limberg flap reconstruction
and in seven patients (18.9%) in the group treated with one-
time crystallized phenol application (Table 2). In these
seven patients, four were cured completely after the sec-
ond session, one was cured completely after the thirdberg flap reconstruction.
Table 1 Preoperative and postoperative variables ac-
cording to operation type.
Variables Operation type p
Modified Limberg
flap reconstruction
n (%)
Crystallized
phenol
application n (%)
Participants 44 37
Sex (F) 6 (13.6) 8 (21.6) 0.344
Age (y) 25.4  5.9 26  6.6 0.627
Recurrence
rate
3 (6.8) 7 (18.9) 0.173
Total sinus
number
58 (55.2) 47 (44.8) 0.669
Surgical site
infection
8 (18.1) 4 (14.8) 0.271
Presence of
hematoma
8 (18.1) 3 (8.1) 0.214
Wound
dehiscence
7 (15.9) 0 0.011
Length of stay
in hospital
(d)
1.25  0.4 0 <0.001
Follow-up
(mo)
17.9  2.6 16.5  4.4 0.88
Body mass
index
24.2  2.6 24.5  2.7 0.554
Data are presented as n (%) or mean  standard deviation.
Table 2 Recurrence causes.
Normal Recurrence
rate
p
Sex (F) 12 (16.9) 2 (20) 0.344
Age (y) 25.3  6.1 28  6.5 0.212
Body mass
index
24.4  2.6 26.9  2.2 0.001
Surgical site
infection
6 (8.5) 6 (60) <0.001
Presence of
hematoma
8 (11.3) 3 (30) 0.132
Dehiscence 7 (9.9) 0 0.588
Length of stay
in hospital (d)
0.67 0.7 0.922
Follow-up
period (mo)
17.1  3.5 18.4  3.4 0.307
Data are presented as n (%) or mean  standard deviation.
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session.
The success rate after multiple applications of crystal-
lized phenol was found to be 94.5%. Even though the
recurrence rate was higher in one-time crystallized phenol
application, the difference between two groups was not
statistically significant (p Z 0.173).
Higher BMI (overweight, > 24.9 kg/m2) and surgical site
infection were strongly correlated with recurrence rate
(p < 0.001). Age, sex, length of stay in hospital, wounddehiscence, and presence of hematoma had no statistically
significant effect on recurrence.4. Discussion
There have been many treatment options for pilonidal sinus
disease. Most of them are surgical procedures such as pri-
mary repair or secondary intention or flap reconstruction
following excision.15,16 In recent years, minimally invasive
procedures have been suggested for the treatment of
pilonidal sinus, including the application of crystallized
phenol.17 Because the effective treatment of pilonidal
disease should be simple, painless, cost-effective, per-
formed with local anesthesia, and should not require hos-
pitalization, a long time off work, and should have a low
recurrence rate,18 the aim of the present study was to
compare modified Limberg flap reconstruction (1 of the
most convenient surgical procedures) with phenol applica-
tion for the treatment of pilonidal sinus disease.
Phenol is a monosubstituted aromatic hydrocarbon that
has acidic properties. It is in the state of crystalline solid at
room temperature and turns to liquid form at higher tem-
peratures. It can be used as liquid or in its crystallized
form. Crystallized phenol has several advantages over the
liquid formdit has better purity and handling properties
than the liquid variant.19 The most common postoperative
complications after liquid phenol treatment have been re-
ported as skin and fat tissue necrosis due to high phenol
concentration or high-pressure injection.20 Crystallized
phenol becomes liquid at body temperature; it irritates the
inner wall of the pilonidal sinus cavity, induces granulation
and contraction, and then results in closure of the cavity.
This procedure has important advantages as it does not
require operating room conditions and can be performed
under local anesthesia in an outpatient clinic. The proce-
dure has been reported to be well tolerated and
cost-effective, and to result in quicker return to daily ac-
tivities.17,20 Phenol treatment has several advantages: it is
a minimally invasive and outpatient procedure, does not
require hospital stay, and leaves a minimal postoperative
incision scar. Therefore, this procedure has been suggested
to increase the quality of life of patients with pilonidal
disease.21 The only disadvantage of this technique is its
higher recurrence rates when compared with those ob-
tained with flap surgery.22 However, most of the high
recurrence data of phenol treatment have been derived
from one application; subsequent phenol applications could
be easily done and improve success rate.22
The present study was performed in order to compare
crystallized phenol application and modified Limberg flap
reconstruction in terms of age, sex, length of hospital stay,
complications, infection, and recurrence rates, as well as
the recurrence rate in patients with pilonidal sinus disease
after one-time crystallized phenol application was found to
have a higher rate compared with that in patients who
underwent modified Limberg flap reconstruction. However,
the difference was not statistically significant. Crystallized
phenol application was repeated in patients with recur-
rence because it was previously reported that the rate of
success increased with multiple phenol applications.17,21
Figure 3 Postoperative appearance of the application site.
Crystallized phenol application leaves a relatively unremark-
able scar.
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applications.
There are several factors affecting the recurrence rate
in pilonidal sinus disease. The recurrence rate of pilonidal
sinus varies depending on the treatment method and the
follow-up period. It has been previously suggested that the
success rate for phenol applications was poor even after
multiple applications in patients having more than three
sinus orifices or a history of pilonidal cyst abscess
drainage.23 In our study, recurrence was observed in pa-
tients with multiple sinus orifices even after repeated
phenol applications, in agreement with this report. Surgical
site infection and hematoma were also suggested to in-
crease the recurrence rate in pilonidal sinus disease,24e26
whereas the correlation between BMI and recurrence rate
is controversial.25,27 In the present study, surgical site
infection and increased BMI were found to be correlated
with the recurrence rate in both study groups. Although the
occurrence rates of infection and hematoma were lower in
patients treated with phenol application, the difference
between the groups was found to be statistically insignifi-
cant. Also, the rates of wound dehiscence and the length of
stay in hospital were significantly decreased in the group
treated with phenol application. Our data support the
findings previously reported in several studies.14,21,22
Recurrent pilonidal sinus disease that occurs after sur-
gery is usually treated with surgical techniques, whereas
recurrence after crystallized phenol application is treated
with minimally invasive techniques. This is the advantage of
phenol application. It was also previously shown that
phenol application performed to treat patients with
recurrence after the surgery increased the success rate.26
Flap treatment of pilonidal sinus disease is mostly per-
formed under general or spinal anesthesia, whereas in crys-
tallized phenol application local anesthetics are used. Spinal
anesthesia is known as an invasive process with complications
such as headaches and urinary retention, and it is more costly
than local anesthesia. Additionally it requires patient moni-
toring after the procedure.28 In patients who underwent
crystallized phenol treatment, local anesthesia was used and
these patients were discharged on the same day.
A large scar was observed after modified Limberg flap
reconstruction, which generally causes an unpleasant
esthetic look, whereas the scar left following phenol
application is almost unremarkable (Figure 3).
There are several studies comparing crystallized phenol
application as a treatment option for pilonidal sinus disease
with other methods including the flap procedure. Modified
Limberg flap is a relatively new procedure, and it has
several advantages over standard Limberg flap.9
The major aim of the flap surgery in pilonidal sinus is to
prevent recurrence by excising maximum tissue as needed
and lateralizing or flattening the midline. Although the
Limberg flap procedure is an efficient surgical option to
treat pilonidal sinus, recurrence was reported in the lower
pole of the flap, as it stays intact within the intergluteal
sulcus. Yet, the modified Limberg flap procedure, in which
rhomboid excision is tailored asymmetrically to place the
flap laterally, eliminates recurrence, which usually occurs
in the inferior part of the midline.7
To our knowledge, our study is the first to compare
crystallized phenol application with modified Limberg flapin the treatment of pilonidal sinus disease. Although this
study is retrospective and the number of cases is relatively
small, our results clearly showed that crystallized phenol is
superior to modified Limberg flap. We are currently running
a prospective study to add more data to this subject.
In summary, phenol treatment appears to be a conve-
nient treatment of choice for pilonidal sinus disease
because of its many advantages such as being a minimally
invasive procedure, performed under local anesthesia,
higher success rate after multiple applications, and
decreased length of stay in hospital with minimal surgical
scar tissue formation.References
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